Exelixis
The Senior Scientist I, Process Chemistry, at Exelixis will primarily focus on executing in-house process chemistry development, collaborating with medicinal discovery chemists to evaluate synthetic routes for early-stage discovery projects. This role involves facilitating the scale-up of compounds for pre-clinical studies and performing solid-state polymorph screening, with an emphasis on transferring developed processes to contract manufacturing organizations.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Senior Scientist Chemistry (PhD)
AstraZeneca
Postdoctoral Scientist, Medicinal Chemistry
Eli Lilly and Company
Chemist – Discovery Process Chemistry
Merck & Co., Inc.
Scientist, Medicinal Chemistry
Roche
Senior Scientist, Chemistry (Onsite)
Merck & Co., Inc.
Senior Scientist, Chemistry (Onsite)
Merck & Co., Inc.